Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Pune
Clinical trial register · India

Clinical Trials in Pune, 2026

Every study on the ClinicalTrials.gov registry that lists a site in India and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 1120 matching records held by the registry are in this view. Synced 07 Nov 2026, 03:16 UTC
1120
Studies in scope
all four open statuses
608
Recruiting now
open to new participants
218
Lead sponsors
across recruiting studies
Top sites
New Delhi 339 Mumbai 260 Hyderabad 233 Bangalore 199 Pune 186
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca15 Eli Lilly and Company13 Bristol-Myers Squibb12 Novartis Pharmaceuticals12 Pfizer12
Site location
New Delhi339 Mumbai260 Hyderabad233 Bangalore199 Pune186
All 274 locations
Target enrolment
to

Trials with a site in Pune

186 of 1120 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Indian sites
Start
Not yet open
Bristol-Myers Squibb
Phase 3
2,380
Belagavi, Nagpur, Pune, New Delhi, Dehradun, Kolkata, Ahemdabad, Bangalore
2026-12-16
Not yet open
Eli Lilly and Company
Phase 3
3,000
Belagavi, Guntur, Guwahati, Mumbai, Nagpur, Pune, Rishikesh, Surat
2026-12
Not yet open
Bristol-Myers Squibb
Phase 4
40
Nashik, Mumbai, Navi Mumbai, Pune, Bhubaneswar, Chennai, Nagpur, New Delhi
2026-11-15
Not yet open
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 2
900
Pune, Chennai
2026-10-30
Not yet open
Wockhardt
Phase 3
324
Gurgaon, Mumbai, Pune, New Delhi, Pimpri-Chinchwad, Jaipur, Chengalpattu, Secunderabad
2026-10-28
Not yet open
Indira IVF Hospital Pvt Ltd
Not applicable
830
Patna, Bangalore, Bhāndup, Pune, Delhi, Jaipur, Udaipur, Allahābād
2026-10-05
Not yet open
Bristol-Myers Squibb
Phase 3
176
Belgavi, Kozhikode, Nashik, Pune, Sakri, Kanpur, Kolkata, Nagpur
2026-10-02
Not yet open
The Primary Prevention of Intimate Partner Violence
NCT06811922Intimate Partner Violence
Emory University
Not applicable
1,700
Mumbai, Pune
2026-10
Recruiting
AstraZeneca
Phase 3
950
Ansārinagar, Bhubaneswar, Hyderabad, Mumbai, Nagpur, Nashik, New Delhi, Pune
2026-09-16
Recruiting
Takeda
Phase 3
324
Gurgaon, Kochi, Thiruvananthapuram, Pune, New Delhi, Rohini, Chennai, Hyderabad
2026-09-10
Recruiting
Bristol-Myers Squibb
Phase 3
850
Vadodara, Badsa, Gurgaon, Belagavi, Pune, Mohali, Chennai
2026-09-08
Recruiting
AstraZeneca
Phase 3
1,072
Hyderabad, Kolkata, New Delhi, Pune
2026-08-31
Recruiting
AstraZeneca
Phase 3
1,500
Bangalore, Indore, Kolkata, Nagpur, Noida, Pune, Siliguri, Visakhapatnam
2026-08-20
Active, closed
Rousselot BVBA
Not applicable
72
Nashik, Navi Mumbai, Pimpri-Chinchwad, Pune, Thane
2026-07-27
Not yet open
Indira IVF Hospital Pvt Ltd
Not applicable
860
Patna, Bangalore, Bhāndup, Pune, Delhi, Jaipur, Allahābād, Lucknow
2026-07-17
Recruiting
Pfizer
Phase 3
540
Visakhapatnam, Bangalore, Belagavi, Nashik, Pune, Dwarka, New Delhi, Jaipur
2026-06-22
Not yet open
Clinical Thresholds of Double-strand Breaks in Sperm's DNA in ART
NCT07621991Sperm DNA Fragmentation, Sperm DNA Impact on ART Outcomes
Indira IVF Hospital Pvt Ltd
Observational
484
Bangalore, Pune
2026-06-01
Recruiting
Janssen Research & Development, LLC
Phase 3
700
Bengaluru, Gūrgaon, Jaipur, Kolkata, New Delhi, Pune
2026-05-31
Recruiting
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
NCT07357727Primary Myelofibrosis (PMF), Post-polycythemia Vera Myelofibrosis (PPV-MF), Post-essential Thrombocythemia Myelofibrosis (PET-MF)
DrugsPelabresib·Ruxolitinib
Novartis Pharmaceuticals
Phase 3
460
Chhatrapati Sambhajinagar, Pune, Rishikesh, Kolkata, Delhi
2026-05-27
Recruiting
Takeda
Phase 3
300
Kochi, Pune, Vellore, Hyderabad, Chandigarh, Delhi
2026-05-21
Recruiting
Laboratoires Thea
Phase 2
120
Kolkata, Ahmedabad, Bangalore, Hyderabad, Jaipur, Patna, Pune, Surat
2026-03-24
Recruiting
Boehringer Ingelheim
Phase 2
132
Ahmedabad, Bhubaneswar, Hyderabad, Kozhikode, Lucknow, Pune, Varanasi
2026-03-23
Recruiting
Johns Hopkins University
Not applicable
690
Mangalore, Pune
2026-03-18
Recruiting
Hoffmann-La Roche
Phase 3
2,000
Ahmedabad, Trivandrum, Mumbai, Pune
2026-03-16
Recruiting
Bristol-Myers Squibb
Phase 2/3
690
Nashik, Mumbai, Delhi, Puducherry, Pune
2026-03-13
Recruiting
Bristol-Myers Squibb
Phase 3
750
Visakhapatnam, Goraj, Mumbai, Nagpur, Dwarka, Hyderabad, Delhi, Pune
2026-03-12
Recruiting
Bristol-Myers Squibb
Phase 1
46
Hyderabad, Ahmedabad, Bangalore, Mysuru, Nagpur, Pune, Bhubaneswar, Secunderabad
2026-02-27
Recruiting
YOXLO B.V.
Not applicable
16
Pune
2026-02-12
Recruiting
Eli Lilly and Company
Phase 3
800
Bengaluru, Bhubaneswar, Guntur, Nagpur, New Delhi, Pune, Raipur, Rishikesh
2026-02-10
Recruiting
Eli Lilly and Company
Phase 2
450
Bhopal, Chhatrapati Sambhajinagar, Dharwad, Karjat, Kolhāpur, Lucknow, Navi Mumbai, Pune
2026-02-10
Recruiting
Sun Pharmaceutical Industries Limited
Phase 2
285
Guntur, Bangalore, Kozhikode, Trivandrum, Kolhāpur, Mumbai, Pune, New Delhi
2026-01-20
Recruiting
Bristol-Myers Squibb
Phase 2/3
990
Nashik, Thiruvananthapuram, Mumbai, Delhi, Puducherry, Pune
2025-12-31
Recruiting
Sanofi
Phase 3
85
Bengaluru, Mumbai, Pune, Vellore
2025-12-18
Active, closed
AstraZeneca
Not applicable
21
Hyderabad, Jhānsi, Kanpur, Kolkata, Mysore, Nagpur, Pune, Vidyanagar, Hubballi
2025-12-10
By invitation
Celldex Therapeutics
Phase 3
1,370
Surat, Vadodara, Mysore, Nagpur, Nashik, Pune, Kanpur
2025-11-25
Recruiting
Eli Lilly and Company
Phase 2
252
Ahmedabad, Chennai, Coimbatore, Hubli, Hyderabad, New Delhi, Pune, Rajkot
2025-11-10
Recruiting
Daiichi Sankyo
Phase 3
686
Bangalore, Bhubaneswar, Howrah, Mangalore, Pune, Surat
2025-10-24
Recruiting
Eli Lilly and Company
Phase 2
531
Bangalore, Bhubaneswar, Chhatrapati Sambhajinagar, Dwārka, Kanpur, New Delhi, Pune, Raipur
2025-10-22
Recruiting
Natureceuticals Sdn Bhd
Phase 3
250
Visakhapatnam, Mysore, Jalgaon, Pune, Erode, Kanpur
2025-10-01
Recruiting
Nuvastatic® Phase III Trial for Fatigue in Triple-Negative Breast Cancer
NCT07669467Fatigue Related to Cancer Treatment, Breast Cancer
DrugNuvastatic 300
Natureceuticals Sdn Bhd
Phase 3
250
Visakhapatnam, Mysore, Jalgaon, Pune, Erode, Kanpur
2025-10-01
Not yet open
Hirabai Cowasji Jehangir Medical Research Institute
Observational
370
Pune
2025-09-29
Recruiting
Pfizer
Phase 3
680
Mumbai, Pune, New Delhi, Kolkata, Delhi, Kerala
2025-09-29
Recruiting
Kashiv BioSciences, LLC
Phase 1
40
Pune
2025-08-18
Recruiting
Sun Pharma Advanced Research Company Limited
Phase 1
177
Rohtak, Ernākulam, Mumbai, Pune, Delhi, Bikaner, Udaipur
2025-08-12
Recruiting
Pfizer
Phase 3
400
Surat, Gurugram, Bengaluru, Mumbai, Nashik, Pune, Thane, Bhubaneswar
2025-08-05
Active, closed
Sanofi
Phase 4
110
Bengaluru, Jaipur, Kolkata, Nagpur, New Delhi, Pune, Vizianagaram
2025-07-31
Recruiting
AbbVie
Phase 4
100
Gurgaon, Bengaluru, Thiruvananthapuram, Mumbai, Pune, New Delhi, Bhubaneswar, Chennai
2025-07-24
Recruiting
Pfizer
Phase 3
714
Bengaluru, Mumbai, Pune, Thane, New Delhi, Hyderabad
2025-07-23
Active, closed
Technical University of Munich
Not applicable
2,276
Pune
2025-07-15
Not yet open
Vedic Lifesciences Pvt. Ltd.
Not applicable
100
Vadodara, Nashik, Pune, New Delhi, Varanasi
2025-06-25
Recruiting
Biogen
Phase 3
180
Hyderabad, Bangalore, Pune, New Delhi, Lucknow, Varanasi, Kolkata, Chandigarh
2025-05-22
Recruiting
Eli Lilly and Company
Phase 3
700
Ahmedabad, Chennai, Chhatrapati Sambhajinagar, Mumbai, Namakkal, Patna, Pune, Thalassery
2025-03-27
Recruiting
Daiichi Sankyo
Phase 3
582
Ahmedabad, Delhi, Kolkata, Mumbai, Nagpur, Nashik, Pune, Vadodara
2025-03-19
Recruiting
AstraZeneca
Phase 3
5,000
Bangalore, Belagavi, Hyderabad, Kolkata, Madurai, Mumbai, New Delhi, Pune
2025-03-03
Recruiting
Dr. D. Y. Patil Dental College & Hospital
Phase 3
40
Pune
2025-02-25
Not yet open
Vedic Lifesciences Pvt. Ltd.
Not applicable
150
Ahmedabad, Pune, Jaipur, Varanasi, Delhi
2025-02-10
Recruiting
Shortened Regimen for Drug-susceptible TB in Children
NCT06253715Tuberculosis, Tuberculosis, Pulmonary, Tuberculosis, Lymph Node, Mycobacterium Tuberculosis
DrugsRifapentine·Rifampin·Pyrazinamide·Isoniazid
Johns Hopkins University
Phase 3
860
Chennai, Pune
2025-01-15
Recruiting
Aurigene Discovery Technologies Limited
Phase 1
40
Vadodara, Jhajjar, Bangalore, Chhatrapati Sambhajinagar, Nagpur, Pune, Satara, Thane
2025-01-15
Active, closed
Pfizer
Phase 3
1,035
Surat, Gurugram, Bangalore, Mumbai, Nashik, Pune, Thane, New Delhi
2025-01-06
Active, closed
AstraZeneca
Phase 4
100
Bangalore, Delhi, Kochi, Mumbai, New Delhi, Pune, Varanasi
2025-01-02
Recruiting
GlaxoSmithKline
Phase 3
520
Ahmedabad, Bangalore, Hyderabad, Kolkata, Pune, Sushrut Hospital and Research
2024-12-16
Recruiting
Janssen Research & Development, LLC
Phase 3
700
Delhi, Hyderabad, Kolkata, Mumbai, New Delhi, Pune, Varanasi, Vellore
2024-12-12
Recruiting
ICU-related Out of Pocket Expenses (ICOPE)
NCT07439692Cost of ICU, Out of Pocket Expenses
Nat Intensive Care Surveillance - MORU
Observational
354
Mysore, Kochi, Pune, New Delhi, Chennai
2024-12-01
Active, closed
Automated Arthritis Detection Using Artificial Intelligence on Smartphone Photographs
NCT06715488Rheumatoid Arthritis &Amp; Other Inflammatory Polyarthropathies, Peripheral Spondyloarthritis, Inflammatory Arthritis
Med2Measure
Observational
3,000
Pune
2024-11-15
Recruiting
Janssen Research & Development, LLC
Phase 3
1,000
Delhi, Kolkata, Mumbai, Pune, Varanasi
2024-10-18
Recruiting
The Archer-Daniels-Midland Company
Not applicable
126
Vadodara, Nashik, Pune, Sopāra, Vasai
2024-10-15
Recruiting
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
NCT06528314NASH - Nonalcoholic Steatohepatitis, MASH - Metabolic Dysfunction-Associated Steatohepatitis
DrugEfruxifermin
Akero Therapeutics, Inc
Phase 3
2,150
Hyderabad, Surat, Vadodara, Mysore, Thiruvananthapuram, Mumbai, Nagpur, Pune
2024-10-04
Active, closed
AstraZeneca
Phase 3
768
Hyderabad, Kolhāpur, Mumbai, Namakkal, Pune, Ranchi, Thane, Varanasi
2024-10-04
By invitation
Sanofi
Phase 2
900
Calicut, Hyderabad, Kanpur, Nagpur, Pune
2024-09-30
Recruiting
Pfizer
Phase 2
48
Surat, Bengaluru, Pune, Lucknow, Kolkata
2024-09-25
Recruiting
Takeda
Phase 4
124
Vijayawada, Guwahati, Surat, Bangalore, Puducherry, Nashik, Navi Mumbai, Pune
2024-08-28
Active, closed
Utilization of Maternal Healthcare Services and Infant Feeding Practices
NCT06601439Maternal Health, Prenatal Care, Feeding Patterns
Hirabai Cowasji Jehangir Medical Research Institute
Observational
500
Pune
2024-08-05
Active, closed
Celldex Therapeutics
Phase 3
976
Surat, Vadodara, Nagpur, Nashik, Pune, Jaipur, Kanpur, Ahmedabad
2024-07-19
Recruiting
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)
Phase 2
385
Ahmedabad, Bhubaneswar, Coimbatore, Jaipur, Kochi, Ludhiana, New Delhi, Pune
2024-07-18
Recruiting
Study of WAL0921 in Patients With Glomerular Kidney Diseases
NCT06466135Diabetic Nephropathies, Primary Focal Segmental Glomerulosclerosis, Minimal Change Disease, Primary Immunoglobulin A Nephropathy
Walden Biosciences
Phase 2
96
Raipur, Nadiād, Vadodara, Bangalore, Pune, Sambhajinagar, New Delhi, Patparganj
2024-07-02
Recruiting
Nemours Children's Clinic
Not applicable
800
Belagavi, Chandrapur, Nagpur, Pune, Wardha, Jaipur, Hyderabad
2024-07-01
Recruiting
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Phase 3
264
Hyderabad, Bangalore, Mangalore, Nashik, Pune
2024-06-25
By invitation
Hirabai Cowasji Jehangir Medical Research Institute
Observational
400
Pune
2024-06-25
Recruiting
Community Health Worker-Led Postpartum Diabetes Screening
NCT06209411Diabetes Mellitus, Type 2, Gestational Diabetes
Weill Medical College of Cornell University
Not applicable
330
Pune
2024-06-13
Recruiting
Novartis Pharmaceuticals
Phase 3
550
Ahmedabad, Kozhikode, Kolhāpur, Nagpur, Nashik, Pune, New Delhi
2024-05-21
Recruiting
Novartis Pharmaceuticals
Phase 3
65
Nagpur, Pune
2024-05-08
Active, closed
Sanofi
Phase 3
1,541
Ahmedabad, Belagavi, Chandigarh, Faridabad, Kolkata, Nagpur, Pune
2024-05-08
Recruiting
Octapharma
Phase 3
124
Pune, Bangalore, Chhatrapati Sambhajinagar, Patna
2024-04-30
Active, closed
Efficacy and Safety of ME-015 (Suplatast Tosilate) in Cough Related to Idiopathic Pulmonary Fibrosis (COSMIC-IPF)
NCT05983471Idiopathic Pulmonary Fibrosis, Cough, IPF, Fibrotic Lung Disease
Melius Pharma AB
Phase 2
40
Guntur, Belagavi, Pune, Coimbatore, Kanpur, Kolkata
2024-04-01
Recruiting
GlaxoSmithKline
Phase 3
864
Mumbai, Pune, Bengaluru, Bhubaneswar, Gūrgaon, Hyderabad, Nashik, Nehru Nagar Belagavi Karnataka 590010
2024-03-21
Recruiting
Rhizen Pharmaceuticals SA
Phase 2
40
Vijayawada, Bangalore, Mumbai, Pune, Madurai, Hyderabad, Kolkata
2024-03-04
Active, closed
Novartis Pharmaceuticals
Phase 3
1,466
Hyderabad, Bangalore, Mumbai, Pune, New Delhi, Bhubaneswar, Chennai, Kolkata
2024-02-28
Recruiting
Novartis Pharmaceuticals
Phase 2
108
Belagavi, Mumbai, Pune, Jaipur, Chennai
2024-02-20
Recruiting
Study of Olverembatinib (HQP1351) in Patients With CML-CP
NCT06423911Chronic Myeloid Leukemia, CML, CML, Chronic Phase
DrugsBosutinib·Olverembatinib
Ascentage Pharma Group Inc.
Phase 3
333
Bangalore, Haryāna, Hyderabad, Kolkata, New Delhi, Pune, Thiruvananthapuram
2024-02-05
Active, closed
Janssen Research & Development, LLC
Phase 3
838
Gūrgaon, Lucknow, Pune
2024-01-22
Active, closed
Pfizer
Phase 2
333
Pune, New Delhi
2024-01-09
Active, closed
Bristol-Myers Squibb
Phase 3
190
Ahmedabad, Gurugram, Bengaluru, Pune, New Delhi
2023-12-21
Recruiting
Ascentage Pharma Group Inc.
Phase 3
400
Gandhinagar, Gurugramam, Jhajjar, Bangalore, Mysuru, Navi Mumbai, Pune, Delhi
2023-12-20
Active, closed
Hoffmann-La Roche
Phase 3
1,050
Banglore, Kozhikode, Trivandrum, Mumbai, Pune, Thane
2023-12-11
Recruiting
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 2
330
Pune
2023-12-07
Recruiting
Chinese University of Hong Kong
Not applicable
81
Chandigarh, Hyderabad, Mumbai, Pune
2023-12-01
Recruiting
Akero Therapeutics, Inc
Phase 3
1,650
Surat, Vadodara, Mysore, Thiruvananthapuram, Dahegaon, Mumbai, Nagpur, Pune
2023-12-01
Active, closed
AstraZeneca
Phase 3
1,898
Bangalore, Calicut, Kanpur, Kolkata, Nagpur, New Delhi, Pune, Vadodara
2023-11-21
Active, closed
Akero Therapeutics, Inc
Phase 3
700
Surat, Vadodara, Thiruvananthapuram, Dahegaon, Mumbai, Nagpur, Pune, New Delhi
2023-11-10
Recruiting
Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1)
NCT05862012Relapsed/Refractory Multiple Myeloma
Ichnos Sciences SA
Phase 1
200
Gandhinagar, Bangalore, Pune, Hyderabad
2023-11-01
Active, closed
Bristol-Myers Squibb
Phase 3
1,057
Ahmedabad, Surat, Belagavi, Bhopal, Nagpur, Pune, New Delhi, Mohali
2023-10-25
Recruiting
Novartis Pharmaceuticals
Phase 3
106
Bangalore, Nagpur, Pune, New Delhi, Hyderabad
2023-10-02
Active, closed
Bristol-Myers Squibb
Phase 3
1,255
Ahmedabad, Surat, Belagavi, Bhopal, Nagpur, Pune, New Delhi, Mohali
2023-09-14
Recruiting
GlaxoSmithKline
Phase 3
892
Bengaluru, Ludhiana, Belagavi, Hyderabad, Nashik, Pune
2023-08-01
Active, closed
The Aurum Institute NPC
Phase 4
1,000
Pune
2023-07-19
Active, closed
Hoffmann-La Roche
Phase 3
2,000
Hyderabad, Ahmedabad, Faridabad, Hubli, Nagpur, Pune, Ajmer, Jaipur
2023-06-28
Active, closed
Viatris Innovation GmbH
Phase 3
451
Ahmedabad, Chennai, Hyderabad, Kolkata, Nagpur, Nashik, New Delhi, Pune
2023-06-26
Active, closed
Bristol-Myers Squibb
Phase 3
1,230
Chandigarh, Bangalore, Kochi, Kolhāpur, Nagpur, Pune, Bhubaneswar, Kolkata
2023-06-22
Active, closed
Eli Lilly and Company
Phase 3
3,127
Guntur, Bangalore, Mysore, Nagpur, Pune
2023-06-05
Active, closed
Novartis Pharmaceuticals
Phase 3
288
Ahmedabad, Kozhikode, Kolhāpur, Nagpur, Nashik, Pune, New Delhi, Dehradun
2023-04-21
Active, closed
AstraZeneca
Observational
712
Gurugram, New Delhi, Hyderabad, Bangalore, Chennai, Kolkata, Mumbai, Pune
2023-04-20
Active, closed
Janssen Research & Development, LLC
Phase 3
614
Gūrgaon, Jaipur, Pune
2023-03-29
Active, closed
Janssen Research & Development, LLC
Phase 3
1,135
Bangalore, Chandigarh, Gurugram, Kolkata, Mumbai, Pune
2023-03-23
Active, closed
A Research Study Looking at Long-term Treatment With Mim8 in People With Haemophilia A
NCT05685238Haemophilia A, Haemophilia A With Inhibitors
Novo Nordisk A/S
Phase 3
451
Surat, Mumbai, Pune, Ludhiana, Jaipur, Ranipet, Noida
2023-02-13
By invitation
Tolmar Inc.
Phase 3
250
Surat, Bangalore, Bengaluru, Mysore, Nagpur, Pune, Erode, Varanasi
2022-12-28
Active, closed
Viatris Innovation GmbH
Phase 3
470
Ahmedabad, Bangalore, Chennai, Hyderabad, Jaipur, Nagpur, Nashik, Pune
2022-12-13
Active, closed
Sanofi
Phase 2
187
Gūrgaon, Jaipur, Kochi, Ludhiana, New Delhi, Pune, Rajkot, Secunderabad
2022-11-25
Active, closed
Novo Nordisk A/S
Phase 3
3,400
Surat, Belagavi, Kozhikode, Mumbai, Nagpur, Pune, Delhi, Chandigarh
2022-11-01
Active, closed
Comparative Outcomes Related to Delivery-room Cord Milking In Low-resourced Kountries
NCT03657394Hypoxic-Ischemic Encephalopathy, Birth Asphyxia
Nemours Children's Clinic
Not applicable
3,442
Belagavi, Nagpur, Pune, Chandrapur, Wardha, Jaipur
2022-10-17
Active, closed
Nemours Children's Clinic
Not applicable
3,442
Belagavi, Nagpur, Pune, Chandrapur, Wardha, Jaipur
2022-10-17
Recruiting
NATCO Pharma Ltd.
Phase 2
21
Mumbai, Pune, Hyderabad
2022-09-30
Active, closed
Johns Hopkins University
Not applicable
450
Pune
2022-09-22
Active, closed
AstraZeneca
Phase 3
594
Jaipur, Pune, Surat
2022-09-15
Active, closed
YoUng Adolescents' behaViour, musculoskeletAl heAlth, Growth & Nutrition
NCT05603793Arrest of Bone Development or Growth, Constitutional Delay of Growth and Puberty, Malnutrition, Child, Gestational Diabetes
Hirabai Cowasji Jehangir Medical Research Institute
Observational
1,304
Pune
2022-09-13
Active, closed
Sanofi
Phase 2/3
1,856
Ahmedabad, Belagavi, Chandigarh, Kolkata, Nagpur, Pune
2022-08-22
Recruiting
Intech Biopharm Ltd.
Not applicable
148
Ahmedabad, Belagāve, Kolkata, New Delhi, Pune, Ulhasnagar
2022-08-15
Active, closed
Novo Nordisk A/S
Phase 3
412
Kochi, Pune, New Dehli
2022-08-10
Active, closed
Novartis Pharmaceuticals
Phase 3
506
Ahmedabad, Bangalore, Pune, New Delhi
2022-08-04
Active, closed
Biocad
Phase 3
270
Faridabad, Mangalore, Mumbai, Nagpur, Nashik, New Delhi, Pune, Sangli
2022-08-02
Active, closed
Hoffmann-La Roche
Phase 3
922
Bangalore, Mumbai, Pune, New Delhi, Kolkata
2022-07-18
Active, closed
Sun Pharmaceutical Industries Limited
Phase 3
529
Surat, Belagavi, Hubli, Pune, Bangalore, Chennai, Secunderabad, Sevilla
2022-06-30
Not yet open
University of Zurich
Not applicable
40
Pune
2022-05
By invitation
Otsuka Pharmaceutical Development & Commercialization, Inc.
Phase 2/3
600
Hyderabad, Ahmedabad, Nadiād, Bengaluru, Manipal, Kozhikode, Thiruvananthapuram, Pune
2022-04-05
Active, closed
Novo Nordisk A/S
Phase 3
153
Guwahati, Surat, Kolhāpur, Mumbai, Pune, Cuttack, Jaipur, Noida
2022-03-24
Active, closed
Otsuka Pharmaceutical Development & Commercialization, Inc.
Phase 3
530
Ahmedabad, Nadiād, Bengaluru, Manipal, Kozhikode, Thiruvananthapuram, Chhatrapati Sambhajinagar, Pune
2022-03-15
Active, closed
Genentech, Inc.
Phase 4
218
Hubli, Pune, Ahmedabad, Chennai, Madurai, Kolkata, Chandigarh
2022-02-28
Active, closed
AstraZeneca
Phase 3
363
Ahmedabad, Dehradun, Delhi, Hyderabad, Kolkata, Nadiād, Pune, Secunderabad
2022-02-15
Active, closed
GlaxoSmithKline
Phase 2
366
Belagavi, Coimbatore, Hyderabad, Kanchan Bagh Hyderabad, Mumbai, New Delhi, Pune, Surat
2021-12-14
Active, closed
Regeneron Pharmaceuticals
Phase 3
288
Guntur, Surat, Panjagutta, Udupi, Kochi, Pune, Parel, New Delhi
2021-12-14
Active, closed
Novartis Pharmaceuticals
Phase 3
1,007
Kochi, Pune, New Delhi, Amritsar, Hyderabad, Lucknow, Kolkata
2021-12-13
Recruiting
Johnson & Johnson Enterprise Innovation Inc.
Phase 3
500
Bangalore, Chennai, Madurai, Mumbai, Nashik, New Delhi, Pune, Vijayawada
2021-12-10
Active, closed
Immunic AG
Phase 3
1,121
Bangalore, Mangalore, Nagpur, New Delhi, Pune, Shimla, Varanasi
2021-11-18
Recruiting
Pfizer
Phase 3
245
Surat, Mumbai, Pune, Kolkata
2021-11-17
Active, closed
Janssen Research & Development, LLC
Phase 3
776
Bangalore, Gurugram, Kolkata, Mumbai, Nashik, New Delhi, Pune, Thane
2021-11-17
Active, closed
Eli Lilly and Company
Phase 3
874
Bangalore, Thiruvananthapuram, Mumbai, Nagpur, Nashik, Pune, Hyderabad
2021-10-04
Active, closed
Pfizer
Phase 3
599
Surat, Gurugram, Mumbai, Pune, New Delhi, Meerut, Kolkata
2021-05-12
Active, closed
Hoffmann-La Roche
Phase 3
1,188
Ahmedabad, Bangalore, Mumbai, Nashik, Pune, New Delhi, North WEST Delhi, Ratnagiri Kilminnal
2021-05-04
Active, closed
Geron Corporation
Phase 3
327
Surat, Bangalore, Bengaluru, New Delhi, Gūrgaon, Bhubaneswar, Kolkata, Pune
2021-04-12
Active, closed
Hoffmann-La Roche
Phase 3
751
Ahmedabad, Mumbai, Pune, New Delhi, Ludhiana, Vadapalani, Chandigarh
2021-03-24
Active, closed
Pfizer
Phase 3
841
Mumbai, Pune, Thane, New Delhi, Jaipur
2020-12-21
Active, closed
Atrasentan in Patients With IgA Nephropathy
NCT04573478IgA Nephropathy, Immunoglobulin A Nephropathy
DrugsAtrasentan·Zigakibart
Novartis Pharmaceuticals
Phase 3
404
Kozhikode, Pune, Vellore, Hyderabad, Secunderabad, Kolkata
2020-12-11
Active, closed
Janssen Research & Development, LLC
Phase 3
518
Amravati, Bangalore, Bikaner, Nashik, New Delhi, Patna, Pune
2020-12-07
Active, closed
Eli Lilly and Company
Phase 3
312
Ahmedabad, Gurugram, Kanpur, Mangalore, Nagpur, New Delhi, Pune
2020-11-25
By invitation
University of Zurich
Not applicable
26
Pune
2020-11-02
Active, closed
Myasthenia Gravis Inebilizumab Trial
NCT04524273Myasthenia Gravis
DrugInebilizumab
Amgen
Phase 3
238
Nagpur, Hyderabad, Bangalore, Lucknow, Manipal, Nashik, Pune, Surat
2020-10-15
Active, closed
Janssen Research & Development, LLC
Phase 3
308
Hyderabad, Kolkata, Mumbai, Nashik, New Delhi, Pune
2020-10-13
Active, closed
Acerta Pharma BV
Phase 3
611
Bangalore, Delhi, Kochi, Mumbai, Nashik, Pune
2020-10-08
Active, closed
Janssen Research & Development, LLC
Phase 3
1,074
Hyderabad, Kolkata, Mumbai, Nashik, Pune
2020-09-30
Recruiting
Epygenix
Phase 3
150
Hyderabad, Surat, Belagavi, Bengaluru, Kochi, Pune, Mumbai, Nagpur
2020-09-15
Active, closed
Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery
NCT04498117Carcinoma, Ovarian Epithelial, Ovarian Neoplasms, Ovarian Cancer, Ovarian Serous Adenocarcinoma
DrugsOregovomab·Paraplatin·Taxol·Paclitaxel
CanariaBio Inc.
Phase 3
615
Bangalore, Bengaluru, Delhi, Mohali, Mumbai, Noida, Pune
2020-08-25
Active, closed
Sarepta Therapeutics, Inc.
Phase 3
160
Ahmedabad, Bengaluru, Hyderabad, Madurai, New Delhi, Pune, Vellore
2020-07-13
Active, closed
Sun Pharmaceutical Industries Limited
Phase 3
296
Surat, Bangalore, Belagavi, Hubli, Pune, Hyderabad, Lucknow, Kochi
2020-07-01
Active, closed
Eli Lilly and Company
Phase 3
996
Chandigarh, Surat, Pune, New Delhi, Ludhiana, Jaipur, Chennai
2020-06-22
Active, closed
Loxo Oncology, Inc.
Phase 3
291
Thiruvananthapuram, Nashik, Pune, Kolkata, Chandigarh
2020-02-11
Active, closed
Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia Without Inhibitors
NCT04082429Haemophilia A Without Inhibitors, Haemophilia B Without Inhibitors
DrugConcizumab
Novo Nordisk A/S
Phase 3
156
Bangalore, Pune, Jaipur, Ranipet
2019-11-13
Active, closed
Novo Nordisk A/S
Phase 3
134
Bangalore, Pune, New Dehli, Ranipet, New Delhi
2019-10-21
Active, closed
Pfizer
Phase 3
896
Surat, Gurgaon, Nagpur, Pune, Jaipur, Kanpur
2019-09-05
Active, closed
Novo Nordisk A/S
Phase 2
62
Kochi, Pune, New Dehli
2019-07-04
Active, closed
AstraZeneca
Phase 3
587
Belagavi, Bengaluru, Gūrgaon, Kolkata, New Delhi, Pune
2019-07-02
Recruiting
Population Health Research Institute
Phase 4
2,270
North Guwāhāti, Ahmedabad, Bangalore, Alappuzha, Thrissur, Puducherry, Pune, Thiruvananthapuram
2019-06-14
Active, closed
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 3
5,832
Pune, Chennai
2019-06-03
Active, closed
Novartis Pharmaceuticals
Phase 3
1,882
Mangalore, Kochi, Mumbai, Pune, New Delhi, Chandigarh, Hyderabad, Howrah
2018-12-28
Active, closed
AstraZeneca
Phase 2
401
Ahmedabad, Jamnagar, Kochi, Mysuru, Nashik, Pune, Thiruvananthapuram
2018-12-21
Active, closed
AstraZeneca
Phase 3
724
Bangalore, Bengaluru, Hyderabad, Kolkata, Madurai, Mumbai, Nashik, Pune
2018-11-30
Active, closed
AstraZeneca
Phase 3
1,246
Gūrgaon, Hubli, Kolkata, Mysuru, Nagpur, Nashik, New Delhi, Pune
2018-09-27
Active, closed
Eli Lilly and Company
Phase 3
1,058
Ahmedabad, Bangalore, Hyderabad, Jaipur, Ludhiana, Nagpur, Noida, Pune
2018-07-18
Active, closed
Eli Lilly and Company
Phase 3
533
Mangalore, Nagpur, New Delhi, Pune
2018-03-14
Active, closed
A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis
NCT03165734Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis
DrugPacritinib
Swedish Orphan Biovitrum
Phase 3
407
Guwahati, Chandigarh, Surat, Gurgaon, Pune, Jaipur, Madurai, Hyderabad
2017-06-26
Active, closed
Pfizer
Phase 3
296
Gurugram, Bangalore, Pune
2017-04-27
Active, closed
Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension
NCT02682511Scleroderma, Diffuse, Scleroderma, Systemic, Scleroderma, Limited, Sclerosis, Progressive Systemic
DrugIfetroban
Cumberland Pharmaceuticals
Phase 2
34
Chandigarh, Mumbai, Pune
2017-01
Active, closed
Eli Lilly and Company
Phase 3
463
Ahmedabad, Bangalore, Mumbai, Pune, New Delhi, Ranipet, Kolkata
2016-12-05
Active, closed
Kem Hospital, Pune, India
Observational
323
Pune
2016-06-10
Active, closed
CINC424A2X01B Rollover Protocol
NCT02386800Primary Myelofibrosis, Polycythemia Vera, Graft Versus Host Disease, Acute Myeloid Leukemia
DrugsPanobinostat·Jakavi·Ruxolitinib
Novartis Pharmaceuticals
Phase 4
279
Pune
2015-03-05
Active, closed
Karyopharm Therapeutics Inc
Phase 2
244
Patna, Vadapalani, Delhi, Thiruvananthapuram, Mumbai, Pune, New Delhi, Bhubaneswar
2014-11
Active, closed
ImmunityBio, Inc.
Phase 1/2
369
Visakhapatnam, Adyār, Ahmedabad, Chhatrapati Sambhajinagar, Nagpur, Pune, Mumbai, New Delhi
2014-07-21
Active, closed
Tata Memorial Hospital
Phase 3
1,600
Guwahati, Ahmedabad, Kannur, Kolhāpur, Mumbai, Pune, Sangli, Shillong
2011-12-12
Rows per page Showing 1–186 of 186
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Indian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 7 November 2026. https://priyalifescience.com/clinical-trials-india/city/pune

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in India and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 1,120 studies in total at the last sync on 07 Nov 2026, 03:16 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 186 of those studies with a site in Pune.

How many clinical trials are recruiting in Pune?

73 of the 186 studies on this page are recruiting new participants as of the 07 Nov 2026, 03:16 UTC sync. A further 14 have not yet opened recruitment, 93 are active but closed to new participants, and 6 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Pune), 186 studies
PhaseStudiesRecruitingShare
Phase 31154261.8%
Phase 2231312.4%
Not applicable20710.8%
Observational914.8%
Phase 4934.8%
Phase 1552.7%
Phase 2/3422.2%
Phase 1/2100.5%

Most active sponsors

Lead sponsors with the most studies (Pune)
Lead sponsorStudiesRecruiting
AstraZeneca154
Eli Lilly and Company135
Bristol-Myers Squibb125
Novartis Pharmaceuticals125
Pfizer126
Janssen Research & Development, LLC103
Novo Nordisk A/S70
Hoffmann-La Roche61
Sanofi61
GlaxoSmithKline43
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.